Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype
- PMID: 24627585
- PMCID: PMC3949258
- DOI: 10.3748/wjg.v20.i10.2482
Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype
Abstract
Irritable bowel syndrome (IBS) is a common condition characterized by abdominal pain or discomfort, bloating, and altered stool form and passage. Small intestinal bacterial overgrowth (SIBO) is a condition in which there is overgrowth of bacteria in small bowel in excess of 10⁵ colony forming units per milliliter on culture of the upper gut aspirate. Frequency of SIBO varied from 4%-78% among patients with IBS and from 1%-40% among controls. Higher frequency in some studies might be due to fallacious criteria [post-lactulose breath-hydrogen rise 20 PPM above basal within 90 min (early-peak)]. Glucose hydrogen breath test (GHBT) has a low sensitivity to diagnose SIBO. Hence, studies based on GHBT might have under-estimated frequency of SIBO. Therefore, it is important to analyze these studies carefully to evaluate whether the reported association between IBS and SIBO is over or under-projected. This review evaluates studies on association between SIBO and IBS, discordance between different studies, their strength and weakness including methodological issues and evidence on therapeutic manipulation of gut flora on symptoms of IBS.
Keywords: Dysbiosis; Functional bowel disease; Glucose hydrogen breath test; Gut flora; Lactulose hydrogen breath test.
Figures
Similar articles
-
Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122. Eur J Gastroenterol Hepatol. 2014. PMID: 24849768 Clinical Trial.
-
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.Gut Liver. 2017 Mar 15;11(2):196-208. doi: 10.5009/gnl16126. Gut Liver. 2017. PMID: 28274108 Free PMC article. Review.
-
[Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1896-902. doi: 10.3760/cma.j.issn.0376-2491.2016.24.005. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27373356 Chinese.
-
A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.Eur J Gastroenterol Hepatol. 2016 Mar;28(3):281-9. doi: 10.1097/MEG.0000000000000557. Eur J Gastroenterol Hepatol. 2016. PMID: 26731696 Clinical Trial.
-
Abnormal breath testing in IBS: a meta-analysis.Dig Dis Sci. 2010 Sep;55(9):2441-9. doi: 10.1007/s10620-010-1276-4. Epub 2010 May 14. Dig Dis Sci. 2010. PMID: 20467896 Review.
Cited by
-
The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.J Clin Med. 2024 Aug 29;13(17):5124. doi: 10.3390/jcm13175124. J Clin Med. 2024. PMID: 39274340 Free PMC article. Review.
-
Food-Intolerance Genetic Testing: A Useful Tool for the Dietary Management of Chronic Gastrointestinal Disorders.Nutrients. 2024 Aug 16;16(16):2741. doi: 10.3390/nu16162741. Nutrients. 2024. PMID: 39203877 Free PMC article.
-
Pediatric multiple sclerosis: an integrated outlook at the interplay between genetics, environment and brain-gut dysbiosis.AIMS Neurosci. 2023 Aug 23;10(3):232-251. doi: 10.3934/Neuroscience.2023018. eCollection 2023. AIMS Neurosci. 2023. PMID: 37841344 Free PMC article. Review.
-
The Intestinal Microbiome and the Metabolic Syndrome-How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD).Curr Issues Mol Biol. 2023 Aug 31;45(9):7197-7211. doi: 10.3390/cimb45090455. Curr Issues Mol Biol. 2023. PMID: 37754239 Free PMC article. Review.
-
Quantitative whole-tissue 3D imaging reveals bacteria in close association with mouse jejunum mucosa.NPJ Biofilms Microbiomes. 2023 Sep 7;9(1):64. doi: 10.1038/s41522-023-00423-2. NPJ Biofilms Microbiomes. 2023. PMID: 37679412 Free PMC article.
References
-
- Ballou SK, Keefer L. Multicultural considerations in the diagnosis and management of irritable bowel syndrome: a selective summary. Eur J Gastroenterol Hepatol. 2013;25:1127–1133. - PubMed
-
- Gonzales Gamarra RG, Ruiz Sánchez JG, León Jiménez F, Cubas Benavides F, Díaz Vélez C. [Prevalence of irritable bowel syndrome in the adult population of the city of Chiclayo in 2011] Rev Gastroenterol Peru. 2012;32:381–386. - PubMed
-
- Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009;24:1601–1607. - PubMed
-
- Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤ 50 years of age. Scand J Gastroenterol. 2013;48:523–529. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
